Thorax

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER


[Advanced]
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this link to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Add article to my folders
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by BRITTON, J.
Right arrow Articles by KNOX, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by BRITTON, J.
Right arrow Articles by KNOX, A.
Thorax 2000;55:725 ( September )

Editorial

Journal Impact Factors for 1999

The first 100% of the full text of this article appears below.


American Journal of Respiratory and Critical Care Medicine 5.491
American Journal of Respiratory Cell and Molecular Biology 4.541
Thorax 3.437
American Journal of Physiology---Lung Cellular and Molecular Physiology 3.147
Journal of Thoracic and Cardiovascular Surgery 2.986
Clinical and Experimental Allergy 2.702
Journal of Heart and Lung Transplantation 2.438
Chest 2.410
European Respiratory Journal 2.334

The Journal Impact Factors for 1999 have recently been released1 and indicate that Thorax has again increased its impact factor, from 2.861 in 1998 to 3.437 in 1999. Thorax has thus further consolidated its position as the highest ranking specialist respiratory journal after the two American Thoracic Society publications. The position of Thorax in terms of impact factor relative to other selected specialist journals of similar or complementary interest is shown in the table. We are pleased to see this continued improvement in the international status of the journal, and thank all who have helped to achieve it.

The ultimate determinant of the impact factor of the journal is the standard of the papers submitted to us. Thank you to all who have sent us their work. Please send us more!

JOHN BRITTON, ALAN KNOX
Executive Editors

References

1. Institute for Scientific Information Journal Citation Reports 1999. http://jcrweb.com

© 2000 by Thorax


This article has been cited by other articles:


Home page
 JCOHome page
G. V. Scagliotti, D.-M. Shin, H. L. Kindler, M. J. Vasconcelles, U. Keppler, C. Manegold, H. Burris, U. Gatzemeier, J. Blatter, J. T. Symanowski, et al.
Phase II Study of Pemetrexed With and Without Folic Acid and Vitamin B12 as Front-Line Therapy in Malignant Pleural Mesothelioma
J. Clin. Oncol., April 15, 2003; 21(8): 1556 - 1561.
[Abstract] [Full Text] [PDF]

Home page
 ThoraxHome page
A J KNOX and J BRITTON
Journal impact factors for 2000: Thorax flying yet higher
Thorax, August 1, 2001; 56(8): 587 - 587.
[Full Text] [PDF]

Home page
 ThoraxHome page
M. F MUERS and D. J GIRLING
Malignant mesothelioma
Thorax, May 1, 2001; 56(5): 417b - 417.
[Full Text]

Home page
 ThoraxHome page
J BRITTON and A J KNOX
Annual report October 1999 to September 2000
Thorax, December 1, 2000; 55(12): 986 - 986.
[Full Text]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER
Terms and conditions relating to subscriptions purchased online  ¦  Website terms and conditions  ¦  Privacy policy
Copyright © 2000 BMJ Publishing Group Ltd & British Thoracic Society